Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.

Saved in:
Bibliographic Details
Title: Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.
Authors: Holdhoff M; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Ye X; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Strowd RE; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Nabors B; University of Alabama, Birmingham, Alabama, USA., Walbert T; Henry Ford Hospital, Detroit, Michigan, USA., Lieberman FS; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Bagley SJ; University of Pennsylvania, Philadelphia, Pennsylvania, USA., Fiveash JB; University of Alabama, Birmingham, Alabama, USA., Fisher JD; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Desideri S; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Surakus T; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Engelhardt M; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Kaindl T; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Lane HA; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Litherland K; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Grossman SA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Kleinberg LR; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2024 Aug 28; Vol. 6 (1), pp. vdae150. Date of Electronic Publication: 2024 Aug 28 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2632-2498
DOI:10.1093/noajnl/vdae150